TAIM
GSK icon

TD Ameritrade Investment Management’s GSK GSK Stock Holding History

TD Ameritrade Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17
Closed -$1K – 188
2023
Q2 		$1K Hold
17
– – ﹤0.01% 509
2023
Q1 		$1K Sell
17
-33
-66% -$1.16K ﹤0.01% 547
2022
Q4 		$2K Sell
50
-264
-84% -$8.79K ﹤0.01% 490
2022
Q3 		$9K Sell
314
-149
-32% -$5.65K ﹤0.01% 392
2022
Q2 		$25K Sell
463
-624
-57% -$34.4K ﹤0.01% 365
2022
Q1 		$59K Buy
1,087
+507
+87% +$27.5K ﹤0.01% 336
2021
Q4 		$32K Buy
580
+411
+243% +$21.4K ﹤0.01% 384
2021
Q3 		$8K Sell
169
-95
-36% -$4.77K ﹤0.01% 466
2021
Q2 		$13K Buy
264
+39
+17% +$1.87K ﹤0.01% 429
2021
Q1 		$10K Hold
225
– – ﹤0.01% 451
2020
Q4 		$10K Buy
225
+56
+33% +$2.57K ﹤0.01% 451
2020
Q3 		$8K Hold
169
– – ﹤0.01% 466
2020
Q2 		$9K Buy
169
+15
+10% +$770 ﹤0.01% 438
2020
Q1 		$7K Sell
154
-13,873
-99% -$740K ﹤0.01% 456
2019
Q4 		$824K Buy
14,027
+877
+7% +$48.8K 0.01% 138
2019
Q3 		$702K Buy
13,150
+2,543
+24% +$131K 0.01% 147
2019
Q2 		$531K Buy
10,607
+2,053
+24% +$103K ﹤0.01% 147
2019
Q1 		$447K Buy
8,554
+2,612
+44% +$131K ﹤0.01% 141
2018
Q4 		$284K Buy
5,942
+2,365
+66% +$116K ﹤0.01% 141
2018
Q3 		$180K Buy
3,577
+3,210
+875% +$163K ﹤0.01% 141
2018
Q2 		$19K Buy
+367
New +$18.5K ﹤0.01% 192

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TD Ameritrade Investment Management's GSK Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of GSK (GSK) in Q3 2023, closing a stake of 17 shares — an estimated $1K sold.

TD Ameritrade Investment Management first reported a position in GSK in Q2 2018 and held it in 21 quarters. The position peaked at $824K in Q4 2019. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

  • TD Ameritrade Investment Management reported no remaining GSK position as of Q3 2023 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 17 GSK shares in Q3 2023, an estimated $1K.
  • TD Ameritrade Investment Management first reported a position in GSK in Q2 2018 and held it in 21 quarters.
  • TD Ameritrade Investment Management's GSK position peaked at $824K in Q4 2019.
  • 846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.